THAR (Tharimmune Corp) Yalpi foyda bo'yicha sotuv rentabelligi

Tharimmune Corp (THAR) korporativ emblemasi va logotipi

Tharimmune, Inc. (THAR) ilmiy markazlarni uzoq muddatli dasturlar bilan bog'lagan holda maqsadli antitanalarning noyob to'plamini ishlab chiqmoqda. Biznesning muvaffaqiyati barqaror kapital rezervi bilan qo'llab-quvvatlanadigan onkologiya va dermatologiya sohalaridagi test natijalariga bog'liq. Valo martaba rentabelligi operatsion samaradorlikni namoyish etadi va ushbu ko'rsatkich 0.00 darajasida turibdi. Shu bilan birga, Tharimmune, Inc. (THAR) surunkali qichishish hamda teri va jigar yallig'lanishiga qarshi terapiyalarni ishlab chiqmoqda.

Tharimmune (THAR): Yalpi rentabellik 21.02.2024dan 18.02.2026gacha

Tharimmune (THAR) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

Fundamental baholash:THAR Tharimmune Corp
tharimmune.com ishlab chiqargan mahsulot

Yalpi daromadlilik bevosita ishlab chiqarish xarajatlari chegirib tashlanganidan keyingi foyda marjasini o'lchaydi, bu esa xarajatlarni boshqarish samaradorligini va mahsulotning narx belgilash imkoniyatlarini baholash imkonini beradi. Effektiv yalpi marjani tahlil qilish orqali investor moliyaviy daromadlarni yuqori malakali antitellar ishlab chiquvchilarini saqlab qolish xarajatlari bilan solishtirishi mumkin, ularning immuno-onkologiya sohasidagi mahsuldorligi Tharimmune, Inc. (THAR) kompaniyasining innovatsion yechimlari yakuniy tannarxiga bevosita ta'sir qiladi.

Muhim raqobatchilar

Yalpi foyda marjasi BeiGene Ltd. (ONC)|Yalpi foyda bo'yicha rentabellik HALO|Yalpi rentabellik RVMD|Yalpi foyda bo'yicha rentabellik AAPG (Ascentage)|Yalpi foyda bo'yicha rentabellik cgoncology.com CGON|UroGen Pharma - Yalpi foyda bo'yicha rentabellik|Yalpi foyda normasi BCAX|PSNL - Yalpi rentabellik|Yalpi foyda bo'yicha sotuv rentabelligi Erasca Oncology ERAS|delcath.com (DCTH) - Yalpi rentabellik|Y-mAbs Therapeutics - Yalpi foyda normasi|AURA (Aura Biosciences Inc) - Yalpi marja|Yalpi foyda marjasi candeltx.com CADL|Yalpi marja ARAY|SLS (SELLAS Life Sciences Group, Inc.) - Yalpi foyda normasi|Yalpi rentabellik Actuate Therapeutics, Inc. ACTU|citiusonc.com - Yalpi rentabellik|TuHURA Biosciences Inc. - Yalpi marja|TARA - Yalpi marja|FATE (Fate Therapeutics) - Yalpi foyda bo'yicha rentabellik|Yalpi foyda bo'yicha rentabellik Aadi Bioscience, Inc.|Yalpi foyda bo'yicha rentabellik TCRX|Yalpi rentabellik CSBR|Yalpi marja XBIT|Yalpi foyda bo'yicha sotuv rentabelligi CEL-SCI Corp.|Yalpi rentabellik ostherapies.com OSTX|RADX: Sotuvning yalpi rentabelligi|ARTV: Yalpi foyda bo'yicha rentabellik|ANL (Adlai Nortye) - Sotuvning yalpi rentabelligi|Veru (VERU) - Yalpi rentabellik|Yalpi foyda bo'yicha rentabellik Tempest Therapeutics Inc|Yalpi rentabellik Xilio Therapeutics|Sotuvning yalpi rentabelligi RENB (Renovaro Inc.)|Yalpi rentabellik Mural Oncology PLC (MURA)|Yalpi marja Kairos Pharma (KAPA)|Yalpi rentabellik onkuretherapeutics.com OKUR|GDTC: Sotuvning yalpi rentabelligi|CRIS: Yalpi foyda bo'yicha rentabellik|apollomicsinc.com (APLM) - Yalpi foyda bo'yicha rentabellik|ADVB: Yalpi marja|Yalpi foyda bo'yicha rentabellik Genprex|CLDI (Calidi Biotherapeutics, Inc.) - Yalpi marja|Sotuvning yalpi rentabelligi SBFM (Sunshine Biopharma)|Yalpi rentabellik Xenetic Bio (XBIO)|Yalpi rentabellik SLRX (Salarius Pharma)|Kitov Pharma - Yalpi foyda bo'yicha rentabellik|American Oncology Network (AONC) - Yalpi foyda marjasi|BeiGene - Yalpi marja|Checkpoint Therapeutics, Inc. (CKPT) - Yalpi foyda bo'yicha rentabellik|ELEV (Elevation Oncology, Inc.) - Yalpi foyda bo'yicha rentabellik|iCAD Inc. - Yalpi foyda normasi|Yalpi foyda bo'yicha rentabellik IKNA|Yalpi marja notablelabs.com|Yalpi foyda bo'yicha rentabellik VIRX (Viracta Therapeutics Inc.)|MOR - Yalpi foyda marjasi|Yalpi rentabellik NAYA Biosciences NAYA|AAPGV - Yalpi foyda bo'yicha rentabellik